Literature DB >> 2968877

Metformin revisited: its actions and indications for use.

C J Bailey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2968877     DOI： 10.1111/j.1464-5491.1988.tb00996.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  20 in total

1.  Effects of insulin, biguanide antihyperglycaemic agents and beta-adrenergic agonists on pathways of myocardial proteolysis.

Authors:  D P Thorne; T D Lockwood
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

2.  Regulation by metformin of the hexose transport system in vascular endothelial and smooth muscle cells.

Authors:  S Sasson; N Gorowits; H G Joost; G L King; E Cerasi; N Kaiser
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 3.  The management of diabetes mellitus in older individuals.

Authors:  J E Morley; H M Perry
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

4.  Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats.

Authors:  A Handberg; L Kayser; P E Høyer; M Voldstedlund; H P Hansen; J Vinten
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

5.  Anti-diabetic biguanides inhibit hormone-induced intracellular Ca2+ concentration oscillations in rat hepatocytes.

Authors:  J J Ubl; S Chen; J W Stucki
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

6.  Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.

Authors:  V Sarabia; L Lam; E Burdett; L A Leiter; A Klip
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 7.  Therapeutic Concentrations of Metformin: A Systematic Review.

Authors:  Farshad Kajbaf; Marc E De Broe; Jean-Daniel Lalau
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

Review 8.  Management of non-insulin-dependent diabetes mellitus.

Authors:  P J Lefèbvre; A J Scheen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

Authors:  D Giugliano; A Quatraro; G Consoli; A Minei; A Ceriello; N De Rosa; F D'Onofrio
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 10.  Comparative tolerability profiles of oral antidiabetic agents.

Authors:  A J Krentz; R E Ferner; C J Bailey
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.